In HCC, high frequency MAGE genes expressions were reported (Chen et al., 1999; Kobayashi et al., 2000) and MAGEA1 and MAGEA3 were shown to be tumor-specific markers to detect blood dissemination of HCC cells (Mou et al., 2002). The gene discussed is MAGEA3; the disease is hepatocellular carcinoma.